Clinical Trials Logo
  1. Home
  2. Arterial Occlusive Diseases
  3. NCT00209443

A Safety and Efficacy Clinical Study to Evaluate the Narrowing of the Aorto-iliac Arteries While Using Gadodiamide

Arterial Occlusive Diseases Clinical Trial

Official title:
A Multicentre, Phase 3, Open-Label Study to Assess the Efficacy and Safety of 0.1 mmol/kg Omniscan (Gadodiamide Injection) for Magnetic Resonance Angiography (MRA) of the Aorto-iliac Arteries

Clinical Trial Summary

Magnetic Resonance Angiography (MRA) is an examination similar to Magnetic Resonance Imaging (MRI) which uses a magnetic field and a contrast medium when needed to visualize blood flow in the arterial vessels throughout the body.

Gadodiamide, a contrast medium, is already approved and is used to image blood vessels by directly injecting it into the vein, but this procedure has not been formally tested to image the aorto-iliac vessels using MR.

The study is designed to determine the presence or absence of a relevant stenosis (ie greater than/equal to 50%) or occlusion in aorto-iliac arteries. Intra-arterial Digital Subtraction Angiography (IADSA) will be used as the standard of truth.

Clinical Trial Description

GEHC has decided not to provide this detail ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00209443
Study type Interventional
Source GE Healthcare
Contact
Status Completed
Phase Phase 3
Start date September 2004
Completion date February 28, 2006
View Details
See also
  Status Clinical Trial Phase
Completed NCT03724279 - Crossing Atheroma or Thrombus With ByCross Device for Revascularization of Peripheral Arteries of Diameter ≥ 3mm N/A
Recruiting NCT04390672 - Multivessel TALENT N/A
Not yet recruiting NCT02841488 - Ischemic Pain Control With Analgesic Methods Clinical Trial Phase 3
Completed NCT00371371 - Intra-arterial Stem Cell Therapy for Patients With Chronic Limb Ischemia (CLI) Phase 1/Phase 2
Completed NCT00174759 - CASPAR : Clopidogrel and Acetyl Salicylic Acid in Bypass Surgery for Peripheral ARterial Disease Phase 3
Completed NCT00000539 - Arterial Disease Multifactorial Intervention Trial (ADMIT) Phase 3
Recruiting NCT04089943 - The Role of microRNA-210 in Regulating Oxidative Stress in Patients With PAD N/A
Recruiting NCT04343209 - Ammonia N-13 Myocardial Blood Flow Absolute Quantification by PET in Patients With Known or Suspected CAD (Ammonia MAP)
Not yet recruiting NCT05930145 - Results of the Use of Two Stentrievers Simultaneosly Compared With One as a Primary Treatment in Acute Ischemic Stroke N/A
Recruiting NCT04142021 - Safety and Feasibility Evaluation of Planning and Execution of Surgical Revascularization Solely Based on Coronary CTA and FFRCT in Patients With Complex Coronary Artery Disease (FASTTRACK CABG)
Completed NCT03253692 - Prospective Multicenter Registry On Radiation Dose Estimates Of Cardiac CT Angiography in Daily Practice in 2017 (PROTECTION VI)
Recruiting NCT04624854 - Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) Phase 4
Active, not recruiting NCT02921230 - Trial Comparing ELUVIA Versus Bare Metal Stent in Treatment of Superficial Femoral and/or Proximal Popliteal Artery N/A
Recruiting NCT02593994 - IRIS-Onyx Cohort in the IRIS-DES Registry
Completed NCT02008097 - Clinical Benefits of B-Flow Ultrasound N/A
Terminated NCT01462721 - The eSVS® Mesh Randomized Post-Market Study N/A
Completed NCT00282646 - Safety and Feasibility Study of Autologous Bone Marrow Cell Transplantation in Patients With Peripheral Arterial Occlusive Disease (PAOD) Phase 2
Not yet recruiting NCT04956523 - Preliminary Tissue Monitoring During Endovascular Intervention Study
Recruiting NCT05616104 - FLEX FIRST Registry Research Protocol
Not yet recruiting NCT04175197 - LegDeb2 Global Registry for Use of Legflow in Peripheral Arteries